TFSA Picks: 1 Healthcare Value Stock with Significant Growth Opportunities

The extent of value-added services provided by Viemed Healthcare Inc. (TSX:VMD)(NASDAQ:VMD) should add significant intrinsic company value over the long-term.

| More on:

Viemed Healthcare (TSX:VMD)(NASDAQ:VMD) is a participating medicare durable medical equipment supplier that provides post-acute respiratory care services in the United States. The company operates through two wholly-owned subsidiaries, Sleep Management and Home Sleep.

Viemed’s primary objective is to solidify the company’s position as the largest independent leader in home therapy of patients suffering from respiratory diseases that require a high level of service. The company’s programs are designed specifically for payors to gain the ability to treat patients in the home for less total cost and with a superior quality of care.

Organic growth model

The services of the company’s subsidiaries include respiratory disease management, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, and respiratory equipment rentals. Viemed adopts an organic growth model whereby expansion is effectuated through existing service areas as well as in new regions through a cost-efficient launch that reduces location expenses.

Viemed employs more respiratory therapists than any other independent provider in the United States. By focusing overhead costs to personnel that service the patient rather than physical location costs, Viemed anticipates efficiently scaling the company’s business in regions that are currently not being effectively serviced.

Significant growth opportunities

The continued trend of servicing patients in the home rather than in hospitals is aligned with Viemed’s vision, and management anticipates that it will continue to offer growth opportunities for Viemed. Viemed expects to continue to be a solution to the rising health costs in the United States by offering more cost-effective home based solutions while increasing the quality of life for patients fighting serious respiratory diseases.

Revenue from ventilator products represented approximately 87% and 92% of total revenues. Viemed’s management believes that the company’s subsidiaries are poised for organic growth moving forward. The company focuses on disease management and improving the quality of life for respiratory patients through clinical excellence, education and technology.

Variety of service offerings

Viemed’s service offerings are based on effective home treatment with respiratory care practitioners providing therapy and counseling to patients at homes using cutting-edge technology. The company’s home sleep division focuses on providing in-home sleep testing for sleep apnea sufferers.

Further, Viemed is one of the largest independent non-invasive ventilator provider in the United States with a service coverage area of 24 states in the United States and prospects to grow. The company’s respiratory disease management service aims at improving quality of life and reducing hospital re-admissions by using proven methodology and leading technologies such as counseling on proper diet, activity level, smoking cessation and inhaler use.

Value-added services

Viemed sources hardware from vendors and pairs them with industry leading respiratory therapy. The company’s neuromuscular care service is focused on helping neuromuscular patients to breathe more comfortably while living an active, healthier life, and uses respiratory therapy treatments which can lessen the effort required to breathe.

Also, the company’s oxygen therapy service provides the patient with extra oxygen, which is sometimes used to manage certain chronic health problems. Overall, the extent of value-added services provided by Viemed should add significant intrinsic company value over the long term.

Fool contributor Nikhil Kumar has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Viemed Healthcare Inc.

More on Investing

Canadian Dollars bills
Dividend Stocks

Waiting Until 45 to Invest $500 a Month Could Cost You $450,000 by 65

Waiting 10 years to start investing can quietly cost you about $450,000, even if nothing “goes wrong.”

Read more »

3 colorful arrows racing straight up on a black background.
Dividend Stocks

2 Solid High-Yield Canadian Stocks to Own for TFSA Passive Income

These TSX giants have increased their dividends annually for decades.

Read more »

man touches brain to show a good idea
Investing

This Canadian Stock Is Down 40%: I’m Buying it for Life

Boyd Group Services stock has dropped sharply, but Q2 results show record revenue and margin growth. Here's why I'm a…

Read more »

Canadian Dollars bills
Dividend Stocks

1 Canadian Stock Down 13% I’d Buy for $551 in Income

A 5.5% yield after a dividend cut can be the start of a recovery story, not the end of one.

Read more »

man in business suit pulls a piece out of wobbly wooden tower
Dividend Stocks

This Is the Dividend Stock I’d Hold Through Market Volatility

BAM is a blue chip buy‑and‑hold dividend candidate, and this week’s pullback may offer an attractive entry point.

Read more »

hand stacking money coins
Dividend Stocks

This Stock Pays a 3.1% Dividend Every Single Month

Chartwell Retirement Residences pays investors a monthly dividend and just posted its 12th straight quarter of double-digit FFO growth.

Read more »

concept of growth
Investing

3 TSX Dividend Stocks for Yield-Hungry Investors

Pullbacks have pushed the yields on these stocks to attractive levels.

Read more »

TFSA (Tax free savings account) acronym on wooden cubes on the background of stacks of coins
Investing

Here’s How I’d Build the Perfect TFSA This August

A TFSA doesn't have to be complicated, and these two low-cost diversified ETFs prove it.

Read more »